Please login to the form below

Not currently logged in
Email:
Password:

Coagadex

This page shows the latest Coagadex news and features for those working in and with pharma, biotech and healthcare.

CHMP backs orphan drugs Uptravi and Coagadex

CHMP backs orphan drugs Uptravi and Coagadex

A CHMP recommendation is routinely followed within three months by a full European approval from the European Commission, so should see Uptravi, Coagadex and Empliciti licensed in the region by May.

Latest news

  • BPL bags FDA approval for rare bleeding disorder therapy BPL bags FDA approval for rare bleeding disorder therapy

    First drug approved for hereditary Factor X deficiency. UK firm Bio Products Laboratory (BPL) has won US approval for Coagadex, the first drug approved specifically for patients with the rare bleeding ... The company is also in the process of carrying

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...

Infographics